Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05808179 · ClinicalTrials.gov registry record · NA
Shifting Sleep Timing in Teens
A NA study of Sleep and Adolescent Behavior, sponsored by Stanford University.
- Recruiting
- Registry status
- NA
- Development phase
- 160
- Enrollment target
- 1
- Study location
NCT05808179: Recruiting NA study of Sleep and Adolescent Behavior, sponsored by Stanford University.
NCT05808179 is a NA study of Sleep and Adolescent Behavior that is actively recruiting participants, run by Stanford University. The registered enrollment target is 160 participants, below the 4,165-participant average among 151 other Sleep trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05808179, a NA study of Sleep and Adolescent Behavior, is actively recruiting participants, sponsored by Stanford University.
- RECRUITING
- Registry status
- NA
- Development phase
- 160 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to determine whether a combination of a novel lighting intervention and a behavioral intervention are able to increase total sleep time in adolescents. The main questions this trial aims to answer are whether this combination therapy is able to meaningfully increase total sleep time in adolescents, and do so over a sustained period of time, and whether such a changes is associated with concomitant changes in mood and cognitive performance.
Primary Outcome
Average nightly total sleep time
Conditions Studied
Interventions
- DEVICE Light
- BEHAVIORAL CBT
- DEVICE Sham Light
Study Locations (1)
California
- Stanford University - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2022-07-01 |
| Est. Completion | 2026-06-20 |
| Phase | NA |
What NCT05808179 shows while recruiting
NCT05808179 is an interventional study that assigns participants to a tested intervention. The registered 160 participants enrollment target is mid-sized for trials with a published cap, below the 4,165-participant average among 151 other Sleep trials with a reported enrollment target (96% lower).
The record links to 3 conditions, with Sleep appearing as the primary indexed condition, and to 3 interventions - of which Light is the first listed.
NCT05808179 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05808179 about?
NCT05808179 is a clinical study titled "Shifting Sleep Timing in Teens". The goal of this clinical trial is to determine whether a combination of a novel lighting intervention and a behavioral intervention are able to increase total sleep time in adolescents. The main questions this trial aims to answer are whether this combination therapy is able to meaningfully increas...
What is the current status of trial NCT05808179?
This trial is currently recruiting. It is a NA study. The enrollment target is 160 participants. The study started on 2022-07-01. Estimated completion is 2026-06-20.
What conditions does trial NCT05808179 study?
This clinical trial studies the following conditions: Sleep, Adolescent Behavior, Sleep Insufficiency.
What interventions are being tested in trial NCT05808179?
The interventions under investigation include: Light (DEVICE), CBT (BEHAVIORAL), Sham Light (DEVICE).
Who is sponsoring clinical trial NCT05808179?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05808179 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sleep
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05808179's enrollment target sits among peer trials
160 40th of 151 higher than 112 of 151 other Sleep trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Sleep trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Student Exercise and Sleep Timing Study - Part 2
RECRUITING · NA
-
The Effects of Sleep on Human Microbiota: Implications for Health and Disease
RECRUITING · NA
-
The Goodnight Screen Media Study
RECRUITING · NA
-
Black Impact: The Mechanisms Underlying Psychosocial Stress Reduction in a Cardiovascular Health Intervention
RECRUITING · NA
-
The Iowa ACEs and Sleep Cohort and Manipulating Sleep in Young Adults With ACEs Studies
RECRUITING · NA
-
The Effects on Sleep Quality of 1:4 Reishi Liquid Extract
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00501826 · 160 participants · Phase 2
Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
- NCT00932139 · 160 participants · NA
Effect of Electro-Acupuncture on Blood Pressure
- NCT00992901 · 160 participants · Early Phase 1
Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery
- NCT01515527 · 160 participants · Phase 2
Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI